Presence of ApoE4 gene in offspring makes a difference, study finds,,
THURSDAY, Feb. 19 (HealthDay News) -- Middle-age people whose parents had Alzheimer's and who carry the so-called Alzheimer's gene might very well have the memory of someone 15 years older, a new study has found.
This memory decline was not detected in people of middle age whose parents had Alzheimer's but who do not carry the gene, known as ApoE4, according to the study.
About 20 percent to 25 percent of the population have at least one copy of the ApoE4 gene, but not all people with the gene develop Alzheimer's, said study co-author Dr. Sudha Seshadri, an associate professor of neurology at Boston University School of Medicine.
The study involved 715 participants in the ongoing Framingham Heart Study, including 282 whose parents, one or both, had been diagnosed with Alzheimer's or other dementia. The participants averaged 59 years old and were healthy, with no memory complaints, said Seshadri, who is also a senior investigator with the Framingham study.
But when given a battery of cognitive tests, those who logged the lowest scores on verbal and visual memory tasks were people who were carriers of the ApoE4 gene and had parents with dementia.
Seshadri stressed that the neuropsychological tests and brain imaging conducted as part of the study offered a sensitive measurement of memory. The participants were "performing older than they're expected," she said, but added that there were "no memory symptoms associated with this." Participants still tested within the normal range for memory and were living normal lives, she said.
The results suggest that the Alzheimer's gene is facilitating the expression of some other gene, Seshadri said. "It's just giving us a clue that whatever [other] gene we find is going to have an interaction with ApoE," she said.
Finding other genes will require a sample of 10,000 to 20,000 people and the collaboration of several research groups, Seshadri said. But, she predicted that "within the next year or two, I think we are going to find more genes."
The study, which was funded by the U.S. National Institutes of Health and released Wednesday, is to be presented at the American Academy of Neurology's annual meeting, from April 25 to May 2, in Seattle.
But the findings should not send people scurrying for genetic testing, Seshadri and another expert said.
Alzheimer's is "not like Huntington's, where if you have the bad gene and you live long enough you're going to get it," Seshadri said. "E4 explains only part of the risk. Clearly there are other genes out there, but they probably have much smaller effects than ApoE4."
Dr. Gary J. Kennedy, director of the division of geriatric psychiatry at Montefiore Medical Center in New York City, said that the finding "needs to be seen with considerable caution so it doesn't get over interpreted."
For starters, he said, the study has not been peer-reviewed, meaning it has not been scrutinized and evaluated by other experts in the field, a process that precedes publication of research in a major medical journal.
Also, statistics in the abstract of the study do not indicate how big a risk factor carrying the ApoE4 gene is for those whose parents had dementia or Alzheimer's, Kennedy said, and the brain scans of the study participants did not show any volumetric changes. "If they saw volumetric changes, that would be scary," Kennedy said.
The bottom line then, according to Seshadri, is that 50-somethings who begin to lose their car keys don't need to start worrying as a result of this study.
"Those of us who lose our keys actually have pretty good memories," she said. "We remember we lost our keys." Besides, she said, people lose their keys "mainly because we were thinking of 15 other things when we put our keys down."
The National Institute on Aging has more on Alzheimer's and genetics.
SOURCES: Sudha Seshadri, M.D., professor, neurology, and director, Alzheimer's Disease Center, University of California, Davis; Gary J. Kennedy, chief, geriatric psychiatry, and director, department of geriatric psychiatry, Montefiore Medical Center, New York City; Feb. 18, 2009, American Academy of Neurology, news release
All rights reserved